Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 28, Pages 23418-23426Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M112.381723
Keywords
-
Categories
Funding
- Canadian Institutes of Health Research [MOP 89793]
- Alberta Innovates-Health Solutions
Ask authors/readers for more resources
The increased prevalence of obesity and diabetes in human populations can induce the deposition of fat (triacylglycerol) in the liver (steatosis). The current view is that most hepatic triacylglycerols are derived from fatty acids released from adipose tissue. In this study, we show that phosphatidylcholine (PC), an important structural component of cell membranes and plasma lipoproteins, can be a precursor of similar to 65% of the triacylglycerols in liver. Mice were injected with [H-3]PC-labeled high density lipoproteins (HDLs). Hepatic uptake of HDL-PC was similar to 10 mu mol/day, similar to the rate of hepatic de novo PC synthesis. Consistent with this finding, measurement of the specific radioactivity of PC in plasma and liver indicated that 50% of hepatic PC is derived from the circulation. Moreover, one-third of HDL-derived PC was converted into triacylglycerols. Importantly, similar to 65% of the total hepatic pool of triacylglycerol appears to be derived from hepatic PC, half of which is derived from HDL. Thus, lipoprotein-associated PC should be considered a quantitatively significant source of triacylglycerol for the etiology of hepatic steatosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available